about
Insights from modeling the 3D structure of New Delhi metallo-β-lactamse and its binding interactions with antibiotic drugsInsights into the mutation-induced HHH syndrome from modeling human mitochondrial ornithine transporter-1.An allosteric mechanism inferred from molecular dynamics simulations on phospholamban pentamer in lipid membranesDrug candidates from traditional chinese medicines.Structure of cytochrome p450s and personalized drug.Molecular modeling of cytochrome P450 and drug metabolism.Recent advances in computational studies on influenza a virus M2 proton channel.Metallo-β-lactamases: structural features, antibiotic recognition, inhibition, and inhibitor design.Research/review: Structure and linkage disequilibrium analysis of adamantane resistant mutations in influenza virus m2 proton channel.Research/review: Insights into the mutation-induced dysfunction of arachidonic acid metabolism from modeling of human CYP2J2.Insights from modeling the 3D structure of NAD(P)H-dependent D-xylose reductase of Pichia stipitis and its binding interactions with NAD and NADP.The computational model to predict accurately inhibitory activity for inhibitors towards CYP3A4.Insights from studying the mutation-induced allostery in the M2 proton channel by molecular dynamics.Insight into the molecular switch mechanism of human Rab5a from molecular dynamics simulations.Insights from investigating the interactions of adamantane-based drugs with the M2 proton channel from the H1N1 swine virus.Molecular simulation to investigate the cofactor specificity for pichia stipitis Xylose reductase.Binding mechanism of H5N1 influenza virus neuraminidase with ligands and its implication for drug design.Binding of CYP2C9 with diverse drugs and its implications for metabolic mechanism.Possible drug candidates for Alzheimer's disease deduced from studying their binding interactions with alpha7 nicotinic acetylcholine receptor.Molecular dynamics studies on the interactions of PTP1B with inhibitors: from the first phosphate-binding site to the second one.Molecular modeling of two CYP2C19 SNPs and its implications for personalized drug design.SCYPPred: a web-based predictor of SNPs for human cytochrome P450.Predicting protein-ligand binding sites based on an improved geometric algorithm.
P50
Q28477703-AA0E82C0-B5C5-4D40-B81E-27DDB18A17D7Q30412384-D84FF08F-EB3A-418B-94E0-A344EF54B3C5Q31007659-4A1329F2-2CB9-4E69-8AD5-D510F0C526A8Q34902194-07FB23E2-13A7-4587-8A81-45950C399F47Q37370400-6438B1D9-9798-484D-8049-2D7001224B7BQ37743544-EA73C041-1A91-484C-9C94-50D924B19AC5Q37993907-C791D131-A838-4605-A998-F0F5D6B9E1EBQ38104436-864D96D4-6C5E-47DA-9362-FAF3657DED46Q38218561-8AE94F47-E753-4AC2-A9F4-DCCE99719063Q38247595-2A147564-FA4A-4CED-9FD4-BCE031D84F0FQ42622708-5F8833B0-D579-47C4-99F4-24448B38B4CBQ42856840-A925B96D-361A-47A8-BDE8-F75ADE0569A9Q43008548-2538E645-405B-4C11-A36F-45C2F71FF27EQ43264077-FC70B478-7B65-4742-947C-1F12C912F793Q43295628-AEBA5FBC-7D75-4031-95A4-32B6A81C10D8Q44342243-DB208B22-D0FC-4A7F-9AA7-BBC381B8EC66Q45384521-867EB349-57EF-4FFD-815E-64EBDB13983DQ46012256-C1369B73-8A53-46B2-B6FC-CF37F9066D87Q46012258-9FF75370-B1BC-44F2-995E-CC2000E81780Q46043876-D7945732-9F06-403A-A295-C6F87F01A3DDQ46790756-07BC01DF-D2F9-4727-8B54-E98E76C6F3A8Q51532000-FE3F03DE-341F-43B7-BD31-35FB00DE1946Q51567580-3E17B08F-D6D3-40A0-B84F-1D5BF3E995B5
P50
name
Jing-Fang Wang
@en
Jing-Fang Wang
@nl
type
label
Jing-Fang Wang
@en
Jing-Fang Wang
@nl
prefLabel
Jing-Fang Wang
@en
Jing-Fang Wang
@nl